Key Insights

Highlights

Treatment Research

10 treatments under study, led by Autologous Hematopoietic Stem Cell Transplantation

Related Conditions

Often studied with 18 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00716066Phase 2Active Not Recruiting

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Showing all 1 trials

Research Network

Common Treatments

  • Autologous Hematopoietic Stem Cell Transplantation1
  • Cytarabine1
  • Peripheral Blood Stem Cell Transplantation1
  • Laboratory Biomarker Analysis1
  • Prednisone1

Active Sponsors

  • Fred Hutchinson Cancer Center1

Top Investigators

Related Conditions

  • Myasthenia Gravis1
  • Multiple Sclerosis Stem Cell Transplant1
  • Opsoclonus Myoclonus Syndrome1
  • Neurologic Autoimmune Disease1
  • Central Nervous System Vasculitis1

Activity Timeline